S Michael Griffin1, Andrew G N Robertson, Albert J Bredenoord, Iain A Brownlee, Rachel Stovold, Malcolm Brodlie, Ian Forrest, John H Dark, Jeff P Pearson, Chris Ward. 1. *Northern Oesophago-Gastric Unit, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom †Department of Gastroenterology, Sint Antonius Hospital, Nieuwegein, The Netherlands ‡Institute for Cell and Molecular Biosciences, Newcastle University, Newcastle upon Tyne, United Kingdom §Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom ¶Department of Cardiothoracic Surgery, Freeman Hospital, Newcastle upon Tyne, United Kingdom.
Abstract
OBJECTIVES: To provide novel pilot data to quantify reflux, aspiration, and allograft injury immediately post-lung transplantation. BACKGROUND: Asymptomatic reflux/aspiration, associated with allograft dysfunction, occurs in lung transplant recipients. Early fundoplication has been advocated. Indications for surgery include elevated biomarkers of aspiration (bile salts) in bronchoalveolar lavage fluid (BALF). Measurements have been mostly documented after the immediate posttransplant period. We report the first prospective study of reflux/aspiration immediately posttransplantation to date. METHODS: Lung transplant recipients were recruited over 12 months. At 1 month posttransplantation, patients completed a Reflux Symptom Index questionnaire and underwent objective assessment for reflux (manometry and pH/impedance). Testing was performed on maintenance proton pump inhibitor. BALF was assessed for pepsin, bile salts, interleukin-8 and neutrophils. RESULTS: Eighteen lung transplant recipients, median age of 46 years (range: 22-59 years), were recruited. Eight of 18 patients had abnormal esophageal peristalsis. Five of 17 patients were positive on Reflux Symptom Index questionnaire. Twelve of 17 patients had reflux. Three patients exclusively had weakly acid reflux. Median acid exposure was 4.8% (range: 1%-79.9%) and median esophageal volume exposure was 1.6% (range: 0.7-5.5). There was a median of 72 reflux events (range: 27-147) per 24 hours. A correlation existed between Reflux Symptom Index score and proximal reflux (r = 0.533, P = 0.006). Pepsin was detected in 11 of 15 BALF samples signifying aspiration (median: 18 ng/mL; range: 0-43). Bile salts were undetectable, using spectrophotometry and rarely detectable using dual mass spectrometry (2/15) (levels 0.2 and 1.2 μmol/L). Lavage interleukin-8 and neutrophil levels were elevated. A correlation existed between proximal reflux events and neutrophilia (r = 0.52, P = 0.03). CONCLUSIONS: Lung transplant recipients should be routinely assessed for reflux/aspiration within the first month posttransplant. Reflux/aspiration can be present early postoperatively. Pepsin was detected suggesting aspiration. Bile salts were rarely detected. Proximal reflux events correlated with neutrophilia, linked to allograft dysfunction and mortality. These results support the need for early assessment of reflux/aspiration, which may inform fundoplication.
OBJECTIVES: To provide novel pilot data to quantify reflux, aspiration, and allograft injury immediately post-lung transplantation. BACKGROUND: Asymptomatic reflux/aspiration, associated with allograft dysfunction, occurs in lung transplant recipients. Early fundoplication has been advocated. Indications for surgery include elevated biomarkers of aspiration (bile salts) in bronchoalveolar lavage fluid (BALF). Measurements have been mostly documented after the immediate posttransplant period. We report the first prospective study of reflux/aspiration immediately posttransplantation to date. METHODS: Lung transplant recipients were recruited over 12 months. At 1 month posttransplantation, patients completed a Reflux Symptom Index questionnaire and underwent objective assessment for reflux (manometry and pH/impedance). Testing was performed on maintenance proton pump inhibitor. BALF was assessed for pepsin, bile salts, interleukin-8 and neutrophils. RESULTS: Eighteen lung transplant recipients, median age of 46 years (range: 22-59 years), were recruited. Eight of 18 patients had abnormal esophageal peristalsis. Five of 17 patients were positive on Reflux Symptom Index questionnaire. Twelve of 17 patients had reflux. Three patients exclusively had weakly acid reflux. Median acid exposure was 4.8% (range: 1%-79.9%) and median esophageal volume exposure was 1.6% (range: 0.7-5.5). There was a median of 72 reflux events (range: 27-147) per 24 hours. A correlation existed between Reflux Symptom Index score and proximal reflux (r = 0.533, P = 0.006). Pepsin was detected in 11 of 15 BALF samples signifying aspiration (median: 18 ng/mL; range: 0-43). Bile salts were undetectable, using spectrophotometry and rarely detectable using dual mass spectrometry (2/15) (levels 0.2 and 1.2 μmol/L). Lavage interleukin-8 and neutrophil levels were elevated. A correlation existed between proximal reflux events and neutrophilia (r = 0.52, P = 0.03). CONCLUSIONS: Lung transplant recipients should be routinely assessed for reflux/aspiration within the first month posttransplant. Reflux/aspiration can be present early postoperatively. Pepsin was detected suggesting aspiration. Bile salts were rarely detected. Proximal reflux events correlated with neutrophilia, linked to allograft dysfunction and mortality. These results support the need for early assessment of reflux/aspiration, which may inform fundoplication.
Authors: Arthur W Baker; Jason E Stout; Deverick J Anderson; Daniel J Sexton; Becky Smith; Rebekah W Moehring; Kirk Huslage; Christopher J Hostler; Sarah S Lewis Journal: Clin Infect Dis Date: 2021-08-02 Impact factor: 9.079
Authors: Chen Yang Kevin Zhang; Musawir Ahmed; Ella Huszti; Liran Levy; Sarah E Hunter; Kristen M Boonstra; Sajad Moshkelgosha; Andrew T Sage; Sassan Azad; Ricardo Zamel; Rasheed Ghany; Jonathan C Yeung; Oscar M Crespin; Courtney Frankel; Marie Budev; Pali Shah; John M Reynolds; Laurie D Snyder; John A Belperio; Lianne G Singer; S Samuel Weigt; Jamie L Todd; Scott M Palmer; Shaf Keshavjee; Tereza Martinu Journal: J Heart Lung Transplant Date: 2020-05-19 Impact factor: 10.247
Authors: Arthur W Baker; Sarah S Lewis; Barbara D Alexander; Luke F Chen; Richard J Wallace; Barbara A Brown-Elliott; Pamela J Isaacs; Lisa C Pickett; Chetan B Patel; Peter K Smith; John M Reynolds; Jill Engel; Cameron R Wolfe; Carmelo A Milano; Jacob N Schroder; Robert D Davis; Matthew G Hartwig; Jason E Stout; Nancy Strittholt; Eileen K Maziarz; Jennifer Horan Saullo; Kevin C Hazen; Richard J Walczak; Ravikiran Vasireddy; Sruthi Vasireddy; Celeste M McKnight; Deverick J Anderson; Daniel J Sexton Journal: Clin Infect Dis Date: 2017-04-01 Impact factor: 9.079
Authors: Paul A Corris; Victoria A Ryan; Therese Small; James Lordan; Andrew J Fisher; Gerard Meachery; Gail Johnson; Chris Ward Journal: Thorax Date: 2015-02-24 Impact factor: 9.139
Authors: Gemma L Zeybel; Jeffrey P Pearson; Amaran Krishnan; Stephen J Bourke; Simon Doe; Alan Anderson; Shoaib Faruqi; Alyn H Morice; Rhys Jones; Melissa McDonnell; Mujdat Zeybel; Peter W Dettmar; Malcolm Brodlie; Chris Ward Journal: J Cyst Fibros Date: 2016-07-27 Impact factor: 5.482
Authors: Ashwini Arjuna; Michael T Olson; Rajat Walia; Ross M Bremner; Michael A Smith; Thalachallour Mohanakumar Journal: Expert Rev Respir Med Date: 2020-10-25 Impact factor: 3.772
Authors: H Al-Momani; A Perry; C J Stewart; R Jones; A Krishnan; A G Robertson; S Bourke; S Doe; S P Cummings; A Anderson; T Forrest; S M Griffin; M Brodlie; J Pearson; C Ward Journal: Sci Rep Date: 2016-06-01 Impact factor: 4.379